Clincosm LogoSign in Get a demo

adenocarcinoma of lung

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of Lung Trial in United States (NovoTTF-200T System)

Not yet recruiting
  • Adenocarcinoma of Lung
  • NovoTTF-200T System
  • Basking Ridge, New Jersey
  • +6 more
Mar 3, 2023

Lung; Node, Adenocarcinoma of Lung Trial in Tampa (DetermaRX)

Recruiting
  • Lung; Node
  • Adenocarcinoma of Lung
  • DetermaRX
  • Tampa, Florida
    Moffitt Cancer Center
Dec 19, 2022

NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +5 more
  • Duarte, California
  • +1 more
Dec 7, 2022

Lung Cancer, Non Small Cell Lung Cancer, Adenocarcinoma of Lung Trial run by the National Cancer Institute (NCI) (LMB-100,

Active, not recruiting
  • Lung Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 4, 2022

Prognostic Value of Lung Cancer MicroAnatomy in 3D

Not yet recruiting
  • Lung Cancer
  • +5 more
  • micro-computed tomography scanning of lung tissue specimens
  • (no location specified)
Oct 1, 2022

APOLLO 11, Consortium of Italian Centers Involved in Treatment

Not yet recruiting
  • NSCLC
  • +4 more
    • (no location specified)
    Sep 19, 2022

    Subjects Treated With Autologous T Cells Using Sleeping Beauty

    Not yet recruiting
    • Gynecologic Cancer
    • +9 more
    • Neoantigen specific TCR-T cell drug product
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 27, 2022

    Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

    Recruiting
    • Gynecologic Cancer
    • +11 more
    • Neoantigen specific TCR-T cell drug product
    • Aldesleukin (IL-2)
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 27, 2022

    Adenocarcinoma of Lung, NSCLC Trial in Rolling Meadows (LP-300, Pemetrexed, Carboplatin)

    Not yet recruiting
    • Adenocarcinoma of Lung
    • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Jul 8, 2022

    Adenocarcinoma of Lung, Lung Cancer Trial in Minneapolis (Oral Restorative Microbiota Therapy (RMT) Capsules, Durvalumab 1500 mg

    Not yet recruiting
    • Adenocarcinoma of Lung
    • Lung Cancer
    • Oral Restorative Microbiota Therapy (RMT) Capsules
    • +3 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Apr 4, 2022

    Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

    Recruiting
    • Lung Neoplasms
    • +3 more
    • Observation
    • Shanghai, China
      Shanghai Chest Hospital
    Mar 14, 2022

    Radiologic Features and Pathologic Subtypes of GGO LUAD Via WMS

    Recruiting
    • Adenocarcinoma of Lung
      • Shanghai, Shanghai, China
        Fudan University Cancer Center
      Feb 13, 2022

      Robotic Arm-assisted PET/CT-guided Lung Biopsy With PET Fused

      Completed
      • Lung Cancer
      • +2 more
      • Robotic arm assisted PET/CT guided biopsy
      • PET fused CT-Fluoroscopy guided biopsy
      • Chandigarh, Chandīgarh, India
        Department of Nuclear Medicine, PGIMER
      Feb 8, 2022

      Liposarcoma, CRC, Prostate Cancer Trial in United States (PF-07220060, Letrozole, Fulvestrant)

      Recruiting
      • Liposarcoma
      • +5 more
      • New Haven, Connecticut
      • +8 more
      Jan 20, 2022

      HRCT in Prediction of Tumor Invasion in GGO Lung Adenocarcinoma

      Completed
      • Adenocarcinoma of Lung
        • Shanghai, Shanghai, China
        • +1 more
        Nov 17, 2021

        Adenocarcinoma of Lung Trial in Beijing (Furmonertinib)

        Not yet recruiting
        • Adenocarcinoma of Lung
        • Beijing, China
          Peking University People's Hospital
        Oct 3, 2021

        Adenocarcinoma of Lung Trial in London (MSCTRAIL, Placebo)

        Recruiting
        • Adenocarcinoma of Lung
        • MSCTRAIL
        • Placebo
        • London, United Kingdom
          University College London Hospital
        Apr 27, 2021

        NSCLC With EGFR Mutation, Locally Advanced Solid Tumor, Metastatic Cancer Trial in Shanghai (Osimertinib, Anlotinib)

        Recruiting
        • Non-Small Cell Lung Cancer With EGFR Mutation
        • +3 more
        • Shanghai, Shanghai, China
          Shanghai Chest hospital
        Feb 24, 2021

        Comparative Genomic Profiling of Lung Adenocarcinoma in Asians

        Not yet recruiting
        • Adenocarcinoma of Lung
          • (no location specified)
          Jan 3, 2021

          NSCLC, Recurrent, Adenocarcinoma of Lung Trial (Vargatef, Abraxane, )

          Withdrawn
          • NSCLC, Recurrent
          • Adenocarcinoma of Lung
          • (no location specified)
          Nov 20, 2020

          Adenocarcinoma of Lung Trial in Seoul (CT-16, Avastin)

          Active, not recruiting
          • Adenocarcinoma of Lung
          • Seoul, Korea, Republic of
            Chung-Ang University Hospital
          Oct 21, 2020

          Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine

          Completed
          • Adenocarcinoma of Lung
          • +6 more
            • Rochester, Minnesota
              Mayo Clinic in Rochester
            Oct 15, 2020

            The Detection of EGFR Mutations in Liquid Based Cytology Samples

            Completed
            • Adenocarcinoma of Lung
              • Truro, Cornwall, United Kingdom
                Cytopathology Laboratory Royal Cornwall Hospital
              Jun 19, 2020

              Non-small Cell Carcinoma, Adenocarcinoma of Lung, Squamous Cell Carcinoma Trial run by the (Drug: Hyperacute Lung Cancer Cell

              Completed
              • Non-small Cell Carcinoma
              • +4 more
              • Drug: Hyperacute Lung Cancer Cell Vaccine
              • Bethesda, Maryland
                National Institutes of Health Clinical Center, 9000 Rockville Pi
              May 26, 2020

              Assessed With Liquid Biopsy of NSCLC Patients in China

              Completed
              • Lung Neoplasms
              • +3 more
                • Guangzhou, Guangdong, China
                • +13 more
                Feb 3, 2020